Nabriva Therapeutics plc
NBRV NASDAQ

NBRV
Nabriva Therapeutics plc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

The current financial position of Nabriva Therapeutics plc

Total assets of NBRV for Q1 21 is 79.41M, 35.89% more than the previous Q4 20. And total liabilities decreased by 3.49% in Q1 21 to 24.42M.

Total assets
Total current assets
Total non-current assets
Total liabilities
Total current liabilities
Total non-current liabilities
Total equity
Total liabilities & shareholders' equities
Total debt
Book value per share